Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 16Unknown 2Withdrawn 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Colorectal Cancer Metastatic 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Lycopene × Clear all
NCT03167268 2021-09-09

PaSTo

Ospedale San Carlo Borromeo

Phase 2 Unknown
28 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT00322114 2013-09-20

Lycopene in Preventing Prostate Cancer in Healthy Participants

National Cancer Institute (NCI)

Phase NA Unknown
150 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡